Natalia Mendoza, MD
Dermatology · Williamsburg, VANPI 1780932129
Payments from drug & device makers
Across 248 payments — averaging $22.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- E.r. Squibb & Sons, L.L.C.$489
- Galderma Laboratories, L.p.$447
- Pfizer$406
- Johnson & Johnson$388
- Novartis$346
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$87315%
- Food & beverage$4,71383%
- Education$1122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 91 | $2,187 |
| E.r. Squibb & Sons, L.L.C. | 18 | $489 |
| Galderma Laboratories, L.p. | 23 | $447 |
| Pfizer | 21 | $406 |
| Johnson & Johnson | 18 | $388 |
| Novartis | 17 | $346 |
| Arcutis Biotherapeutics, Inc. | 11 | $224 |
| UCB, Inc. | 4 | $170 |
| Sun Pharmaceutical Industries Inc. | 8 | $147 |
| LEO Pharma Inc. | 5 | $129 |
| Biofrontera Inc. | 2 | $118 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Alnylam Pharmaceuticals Inc. | 3 | $82 |
| VYNE Pharmaceuticals Inc. | 3 | $66 |
| Incyte Corporation | 4 | $66 |
| Dermavant Sciences, Inc. | 2 | $50 |
| Sanofi | 2 | $39 |
| Blueprint Medicines Corporation | 1 | $38 |
| Organon | 2 | $37 |
| Amgen | 2 | $35 |
| Convatec Inc. | 1 | $33 |
| Merck | 2 | $32 |
| Kerecis Limited | 1 | $25 |
| Dermira, Inc. | 1 | $23 |
| Fresenius Kabi USA, LLC | 1 | $14 |
| Strata Skin Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,697 in reported general payments places this provider in the 65th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 40 | $152,594 |
| Dupixent SyringeDupilumab | 18 | $81,107 |
| Metronidazole | 126 | $7,017 |
| Fluorouracil | 80 | $5,898 |
| Ketoconazole | 250 | $5,412 |
| Clobetasol Propionate | 85 | $4,040 |
| Fluocinonide | 60 | $2,686 |
| Calcipotriene | 24 | $2,295 |
| Triamcinolone Acetonide | 233 | $1,572 |
| Clindamycin Phosphate | 58 | $1,469 |
| Ciclopirox | 59 | $1,419 |
| Tacrolimus | 17 | $1,399 |
| Doxycycline Hyclate | 28 | $1,131 |
| Gentamicin Sulfate | 15 | $737 |
| Betamethasone Valerate | 27 | $733 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Williamsburg
- David PariserNorfolk$7M
- Jennifer DesimoneFairfax$2.3M
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Vishal PatelLeesburg$1.1M
- Diego DasilvaVirginia Beach$1.1M
- Carrie CobbLynchburg$859K
- Yvonne KnightRichmond$857K
- David BrayAlexandria$799K
- Cyndi Torosky TommasoVirginia Beach$717K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.